Determination of picamilon concentration in human plasma by liquid chromatography-tandem mass spectrometry

被引:8
作者
Cui, Wenqi [1 ,2 ]
Chen, Xiaoyan [1 ]
Zhan, Yan [1 ]
Zhang, Zhenzhong [2 ]
Zhang, Yifan [1 ]
Zhong, Dafang [1 ]
机构
[1] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China
[2] Zhengzhou Univ, Zhengzhou 450001, Peoples R China
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2010年 / 878卷 / 15-16期
关键词
Picamilon; LC-MS/MS; Pharmacokinetics; Human plasma;
D O I
10.1016/j.jchromb.2010.03.013
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A rapid liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was developed and validated for the determination of picamilon concentration in human plasma. Picamilon was extracted from human plasma by protein precipitation. High performance liquid chromatography separation was performed on a Venusil ASB C-18 column with a mobile phase consisting of methanol -10 mM ammonium acetate-formic acid (55:45:01, v/v/v) at a flow rate of 0.65 ml/min. Acquisition of mass spectrometric data was performed in selected reaction monitoring mode, using the transitions of m/z 209.0 -> m/z (78.0 + 106.0) for picamilon and m/z 152.0 -> m/z (93.0 + 110.0) for paracetamol (internal standard). The method was linear in the concentration range of 1.00-5000 ng/ml for the analyte. The lower limit of quantification was 1.00 ng/ml. The intra- and inter-assay precision were below 13.5%, and the accuracy was between 99.6% and 101.6%. The method was successfully applied to characterize the pharmacokinetic profiles of picamilon in healthy volunteers. This validated LC-MS/MS method was selective and rapid, and is suitable for the pharmacokinetic study of picamilon in humans. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:1181 / 1184
页数:4
相关论文
共 8 条
  • [1] BENDIKOV EA, 1972, B EKSP BIOL MED, V1, P65
  • [2] DOROFEEV B F, 1991, Farmakologiya i Toksikologiya (Moscow), V54, P66
  • [3] Gunar V. I., 1999, PHARM CHEM J+, V33, P177
  • [4] PRECISION, ACCURACY, AND DATA ACCEPTANCE CRITERIA IN BIOPHARMACEUTICAL ANALYSIS
    KARNES, HT
    MARCH, C
    [J]. PHARMACEUTICAL RESEARCH, 1993, 10 (10) : 1420 - 1426
  • [5] Kruglikova-L'vova RP., 1989, PHARM CHEM J+, V23, P182, DOI [10.1007/BF00764472, DOI 10.1007/BF00764472]
  • [6] The treatment of migraines and tension-type headaches with intravenous and oral niacin (nicotinic acid): systematic review of the literature
    Prousky, Jonathan
    Seely, Dugald
    [J]. NUTRITION JOURNAL, 2005, 4 (1)
  • [7] Bioanalytical Method Validation—A Revisit with a Decade of Progress
    Vinod P. Shah
    Kamal K. Midha
    John W. A. Findlay
    Howard M. Hill
    James D. Hulse
    Iain J. McGilveray
    Gordon McKay
    Krys J. Miller
    Rabindra N. Patnaik
    Mark L. Powell
    Alfred Tonelli
    C. T. Viswanathan
    Avraham Yacobi
    [J]. Pharmaceutical Research, 2000, 17 (12) : 1551 - 1557
  • [8] Quantitative bioanalytical methods validation and implementation: Best practices for chromatographic and ligand binding assays
    Viswanathan, C. T.
    Bansal, Surendra
    Booth, Brian
    DeStefano, Anthony J.
    Rose, Mark J.
    Sailstad, Jeffrey
    Shah, Vinod P.
    Skelly, Jerome P.
    Swann, Patrick G.
    Weiner, Russell
    [J]. PHARMACEUTICAL RESEARCH, 2007, 24 (10) : 1962 - 1973